GLOBUS MEDICAL, INC. Operating Expenses
GLOBUS MEDICAL, INC. (GMED) reported Operating Expenses of $320.03 million for the 3-month period ending 2024-06-30, per its 10-Q filed 2024-08-06.
Discontinued › Expense Statement › Operating Expenses
us-gaap:OperatingExpenses · last filed 2024-08-06
- GLOBUS MEDICAL, INC. operating expenses for the quarter ending 2024-06-30 was $320.03M, a 114.89% increase year-over-year.
- GLOBUS MEDICAL, INC. operating expenses for the quarter ending 2024-03-31 was $357.18M, a 138.98% increase year-over-year.
- GLOBUS MEDICAL, INC. operating expenses for the quarter ending 2023-12-31 was $340.93M, a 127.47% increase year-over-year.
- GLOBUS MEDICAL, INC. operating expenses for the quarter ending 2023-09-30 was $247.84M, a 92.20% increase year-over-year.
- GLOBUS MEDICAL, INC. operating expenses for fiscal 2023 was $887.16M, a 67.02% increase from fiscal 2022.
- GLOBUS MEDICAL, INC. operating expenses for fiscal 2022 was $531.17M, a 2.88% decline from fiscal 2021.
- GLOBUS MEDICAL, INC. operating expenses for fiscal 2021 was $546.93M, a 18.86% increase from fiscal 2020.
- GLOBUS MEDICAL, INC. operating expenses for fiscal 2020 was $460.15M, a 6.17% increase from fiscal 2019.
| Period end | Operating Expenses 3 month | Operating Expenses 3 month as first filed | Operating Expenses 6 month | Operating Expenses 6 month as first filed | Operating Expenses 9 month | Operating Expenses 9 month as first filed | Operating Expenses 12 month | Operating Expenses 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2024-06-30 | $320.03M 10-Q · filed 2024-08-06 | $677.21M 10-Q · filed 2024-08-06 | $1.02B derived: sum of 3 quarters · filed 2024-08-06 | $1.27B derived: sum of 4 quarters · filed 2024-08-06 | ||||
| 2024-03-31 | $357.18M 10-Q · filed 2024-05-07 | $698.11M derived: sum of 2 quarters · filed 2024-05-07 | $945.95M derived: sum of 3 quarters · filed 2024-05-07 | $1.09B derived: sum of 4 quarters · filed 2024-08-06 | ||||
| 2023-12-31 | $340.93M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-21 | $588.77M derived: sum of 2 quarters · filed 2024-02-21 | $737.70M derived: sum of 3 quarters · filed 2024-08-06 | $887.16M 10-K · filed 2024-02-21 | ||||
| 2023-09-30 | $247.84M 10-Q · filed 2023-11-07 | $396.77M derived: sum of 2 quarters · filed 2024-08-06 | $546.24M 10-Q · filed 2023-11-07 | $696.11M derived: sum of 4 quarters · filed 2024-08-06 | ||||
| 2023-06-30 | $148.93M 10-Q · filed 2024-08-06 | $298.39M 10-Q · filed 2024-08-06 | $448.27M derived: sum of 3 quarters · filed 2024-08-06 | $577.22M derived: sum of 4 quarters · filed 2024-08-06 | ||||
| 2023-03-31 | $149.46M 10-Q · filed 2024-05-07 | $299.34M derived: sum of 2 quarters · filed 2024-05-07 | $428.29M derived: sum of 3 quarters · filed 2024-05-07 | $555.69M derived: sum of 4 quarters · filed 2024-05-07 | ||||
| 2022-12-31 | $149.88M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-21 | $278.83M derived: sum of 2 quarters · filed 2024-02-21 | $406.23M derived: sum of 3 quarters · filed 2024-02-21 | $531.17M 10-K · filed 2024-02-21 | ||||
| 2022-09-30 | $128.95M 10-Q · filed 2023-11-07 | $256.35M derived: sum of 2 quarters · filed 2023-11-07 | $381.29M 10-Q · filed 2023-11-07 | $551.31M derived: sum of 4 quarters · filed 2024-02-21 | ||||
| 2022-06-30 | $127.40M 10-Q · filed 2023-08-03 | $252.34M 10-Q · filed 2023-08-03 | $422.36M derived: sum of 3 quarters · filed 2024-02-21 | $540.20M derived: sum of 4 quarters · filed 2024-02-21 | ||||
| 2022-03-31 | $124.94M 10-Q · filed 2023-05-04 | $294.96M derived: sum of 2 quarters · filed 2024-02-21 | $412.80M derived: sum of 3 quarters · filed 2024-02-21 | $554.09M derived: sum of 4 quarters · filed 2024-02-21 | ||||
| 2021-12-31 | $170.03M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-21 | $287.86M derived: sum of 2 quarters · filed 2024-02-21 | $429.16M derived: sum of 3 quarters · filed 2024-02-21 | $546.93M 10-K · filed 2024-02-21 | ||||
| 2021-09-30 | $117.84M 10-Q · filed 2022-11-08 | $259.13M derived: sum of 2 quarters · filed 2022-11-08 | $376.90M 10-Q · filed 2022-11-08 | $490.95M derived: sum of 4 quarters · filed 2023-02-21 | ||||
| 2021-06-30 | $141.29M 10-Q · filed 2022-08-04 | $259.06M 10-Q · filed 2022-08-04 | $373.11M derived: sum of 3 quarters · filed 2023-02-21 | $482.10M derived: sum of 4 quarters · filed 2023-02-21 | ||||
| 2021-03-31 | $117.77M 10-Q · filed 2022-05-10 | $231.82M derived: sum of 2 quarters · filed 2023-02-21 | $340.81M derived: sum of 3 quarters · filed 2023-02-21 | $464.65M derived: sum of 4 quarters · filed 2023-02-21 | ||||
| 2020-12-31 | $114.05M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-21 | $223.04M derived: sum of 2 quarters · filed 2023-02-21 | $346.88M derived: sum of 3 quarters · filed 2023-02-21 | $460.15M 10-K · filed 2023-02-21 | ||||
| 2020-09-30 | $108.99M 10-Q · filed 2021-11-04 | $232.83M derived: sum of 2 quarters · filed 2021-11-04 | $346.10M 10-Q · filed 2021-11-04 | $459.02M derived: sum of 4 quarters · filed 2022-02-17 | ||||
| 2020-06-30 | $123.84M 10-Q · filed 2021-08-04 | $237.11M 10-Q · filed 2021-08-04 | $350.03M derived: sum of 3 quarters · filed 2022-02-17 | $458.80M derived: sum of 4 quarters · filed 2022-02-17 | ||||
| 2020-03-31 | $113.27M 10-Q · filed 2021-05-04 | $226.19M derived: sum of 2 quarters · filed 2022-02-17 | $334.96M derived: sum of 3 quarters · filed 2022-02-17 | $442.64M derived: sum of 4 quarters · filed 2022-02-17 | ||||
| 2019-12-31 | $112.93M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-17 | $221.69M derived: sum of 2 quarters · filed 2022-02-17 | $329.37M derived: sum of 3 quarters · filed 2022-02-17 | $433.40M 10-K · filed 2022-02-17 | ||||
| 2019-09-30 | $108.77M 10-Q · filed 2020-10-28 | $216.45M derived: sum of 2 quarters · filed 2020-10-28 | $320.48M 10-Q · filed 2020-10-28 | $320.48M derived: sum of 4 quarters · filed 2021-02-17 | ||||
| 2019-06-30 | $107.68M 10-Q · filed 2020-08-05 | $211.71M 10-Q · filed 2020-08-05 | $211.71M derived: sum of 3 quarters · filed 2021-02-17 | $304.80M derived: sum of 4 quarters · filed 2021-02-17 | ||||
| 2019-03-31 | $104.03M 10-Q · filed 2020-05-07 | $104.03M derived: sum of 2 quarters · filed 2021-02-17 | $197.12M derived: sum of 3 quarters · filed 2021-02-17 | $290.72M derived: sum of 4 quarters · filed 2021-02-17 | ||||
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-K 9 month · filed 2021-02-17 | $93.09M derived: sum of 2 quarters · filed 2021-02-17 | $186.69M derived: sum of 3 quarters · filed 2021-02-17 | $384.23M 10-K · filed 2021-02-17 | ||||
| 2018-09-30 | $93.09M 10-Q · filed 2019-11-06 | $186.69M derived: sum of 2 quarters · filed 2019-11-06 | $384.23M 10-K · filed 2020-02-20 | $277.50M 10-Q · filed 2018-11-08 | $364.32M derived: sum of 4 quarters · filed 2020-03-02 | |||
| 2018-06-30 | $93.61M 10-Q · filed 2019-08-01 | $184.41M 10-Q · filed 2019-08-01 | $271.23M derived: sum of 3 quarters · filed 2020-03-02 | $350.38M derived: sum of 4 quarters · filed 2020-03-02 | ||||
| 2018-03-31 | $90.81M 10-Q · filed 2019-05-02 | $177.63M derived: sum of 2 quarters · filed 2020-03-02 | $256.78M derived: sum of 3 quarters · filed 2020-03-02 | $334.60M derived: sum of 4 quarters · filed 2020-03-02 | ||||
| 2017-12-31 | $86.82M derived: 10-K/A 12 month − 10-Q 9 month · filed 2020-03-02 | $165.97M derived: sum of 2 quarters · filed 2020-03-02 | $243.79M derived: sum of 3 quarters · filed 2020-03-02 | $323.68M 10-K/A · filed 2020-03-02 | ||||
| 2017-09-30 | $79.15M 10-Q · filed 2018-11-08 | $156.97M derived: sum of 2 quarters · filed 2018-11-08 | $236.87M 10-Q · filed 2018-11-08 | $313.73M derived: sum of 4 quarters · filed 2019-02-21 | ||||
| 2017-06-30 | $77.82M 10-Q · filed 2018-08-02 | $157.72M 10-Q · filed 2018-08-02 | $234.58M derived: sum of 3 quarters · filed 2019-02-21 | $301.13M derived: sum of 4 quarters · filed 2019-02-21 | ||||
| 2017-03-31 | $79.89M 10-Q · filed 2018-05-03 | $156.76M derived: sum of 2 quarters · filed 2019-02-21 | $223.31M derived: sum of 3 quarters · filed 2019-02-21 | $290.15M derived: sum of 4 quarters · filed 2019-02-21 | ||||
| 2016-12-31 | $76.87M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-21 | $143.41M derived: sum of 2 quarters · filed 2019-02-21 | $210.25M derived: sum of 3 quarters · filed 2019-02-21 | $275.15M 10-K · filed 2019-02-21 | ||||
| 2016-09-30 | $66.55M 10-Q · filed 2017-11-09 | $133.39M derived: sum of 2 quarters · filed 2017-11-09 | $198.28M 10-Q · filed 2017-11-09 | $249.93M derived: sum of 4 quarters · filed 2018-02-22 | ||||
| 2016-06-30 | $66.84M 10-Q · filed 2017-08-03 | $66.72M 10-Q · filed 2016-07-27 | $131.73M 10-Q · filed 2017-08-03 | $131.48M 10-Q · filed 2016-07-27 | $183.38M derived: sum of 3 quarters · filed 2018-02-22 | $246.77M derived: sum of 4 quarters · filed 2018-02-22 | ||
| 2016-03-31 | $64.89M 10-Q · filed 2017-05-04 | $64.77M 10-Q · filed 2016-05-04 | $116.54M derived: sum of 2 quarters · filed 2018-02-22 | $179.93M derived: sum of 3 quarters · filed 2018-02-22 | $243.90M derived: sum of 4 quarters · filed 2018-02-22 | |||
| 2015-12-31 | $51.65M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-22 | $115.04M derived: sum of 2 quarters · filed 2018-02-22 | $179.00M derived: sum of 3 quarters · filed 2018-02-22 | $240.20M 10-K · filed 2018-02-22 | $239.73M 10-K · filed 2016-02-29 | |||
| 2015-09-30 | $63.39M 10-Q · filed 2016-11-09 | $63.27M 10-Q · filed 2015-11-04 | $127.35M derived: sum of 2 quarters · filed 2016-11-09 | $188.55M 10-Q · filed 2016-11-09 | $188.20M 10-Q · filed 2015-11-04 | $246.30M derived: sum of 4 quarters · filed 2017-03-16 | ||
| 2015-06-30 | $63.96M 10-Q · filed 2016-07-27 | $124.94M 10-Q · filed 2016-07-27 | $182.91M derived: sum of 3 quarters · filed 2017-03-16 | $238.09M derived: sum of 4 quarters · filed 2017-03-16 | ||||
| 2015-03-31 | $60.98M 10-Q · filed 2016-05-04 | $118.95M derived: sum of 2 quarters · filed 2017-03-16 | $174.12M derived: sum of 3 quarters · filed 2017-03-16 | $229.56M derived: sum of 4 quarters · filed 2017-03-16 | ||||
| 2014-12-31 | $57.97M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-16 | $113.15M derived: sum of 2 quarters · filed 2017-03-16 | $168.58M derived: sum of 3 quarters · filed 2017-03-16 | $225.24M 10-K · filed 2017-03-16 | $225.15M 10-K · filed 2015-02-26 | |||
| 2014-09-30 | $55.18M 10-Q · filed 2015-11-04 | $110.61M derived: sum of 2 quarters · filed 2015-11-04 | $167.27M 10-Q · filed 2015-11-04 | $224.00M derived: sum of 4 quarters · filed 2016-02-29 | ||||
| 2014-06-30 | $55.44M 10-Q · filed 2015-07-31 | $112.09M 10-Q · filed 2015-07-31 | $168.82M derived: sum of 3 quarters · filed 2016-02-29 | $221.19M derived: sum of 4 quarters · filed 2016-02-29 | ||||
| 2014-03-31 | $56.66M 10-Q · filed 2015-05-05 | $113.38M derived: sum of 2 quarters · filed 2016-02-29 | $165.75M derived: sum of 3 quarters · filed 2016-02-29 | $236.81M derived: sum of 4 quarters · filed 2016-02-29 | ||||
| 2013-12-31 | $56.72M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29 | $109.09M derived: sum of 2 quarters · filed 2016-02-29 | $180.15M derived: sum of 3 quarters · filed 2016-02-29 | $232.44M 10-K · filed 2016-02-29 | ||||
| 2013-09-30 | $52.37M 10-Q · filed 2014-10-31 | $123.42M derived: sum of 2 quarters · filed 2014-10-31 | $175.72M 10-Q · filed 2014-10-31 | $227.59M derived: sum of 4 quarters · filed 2015-02-26 | ||||
| 2013-06-30 | $71.06M 10-Q · filed 2014-08-06 | $123.35M 10-Q · filed 2014-08-06 | $175.22M derived: sum of 3 quarters · filed 2015-02-26 | $224.05M derived: sum of 4 quarters · filed 2015-02-26 | ||||
| 2013-03-31 | $52.29M 10-Q · filed 2014-04-30 | $104.16M derived: sum of 2 quarters · filed 2015-02-26 | $153.00M derived: sum of 3 quarters · filed 2015-02-26 | $200.03M derived: sum of 4 quarters · filed 2015-02-26 | ||||
| 2012-12-31 | $51.87M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-26 | $100.70M derived: sum of 2 quarters · filed 2015-02-26 | $147.73M derived: sum of 3 quarters · filed 2015-02-26 | $196.00M 10-K · filed 2015-02-26 | ||||
| 2012-09-30 | $48.83M 10-Q · filed 2013-10-31 | $95.86M derived: sum of 2 quarters · filed 2013-10-31 | $144.13M 10-Q · filed 2013-10-31 | $188.93M derived: sum of 4 quarters · filed 2014-03-14 | ||||
| 2012-06-30 | $47.03M 10-Q · filed 2013-08-02 | $95.30M 10-Q · filed 2013-08-02 | $140.09M derived: sum of 3 quarters · filed 2014-03-14 | $180.69M derived: sum of 4 quarters · filed 2014-03-14 | ||||
| 2012-03-31 | $48.27M 10-Q · filed 2013-05-03 | $93.06M derived: sum of 2 quarters · filed 2014-03-14 | $133.66M derived: sum of 3 quarters · filed 2014-03-14 | $173.52M derived: sum of 4 quarters · filed 2014-03-14 | ||||
| 2011-12-31 | $44.79M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-14 | $85.39M derived: sum of 2 quarters · filed 2014-03-14 | $125.25M derived: sum of 3 quarters · filed 2014-03-14 | $165.32M 10-K · filed 2014-03-14 | ||||
| 2011-09-30 | $40.60M 10-Q · filed 2012-11-02 | $80.46M derived: sum of 2 quarters · filed 2012-11-02 | $120.53M 10-Q · filed 2012-11-02 | |||||
| 2011-06-30 | $39.86M 10-Q/A · filed 2012-09-19 | $79.93M 10-Q/A · filed 2012-09-19 | ||||||
| 2010-12-31 | $146.69M 10-K/A · filed 2013-06-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| HAEMONETICS CORP (HAE) | United States | $4.821B | 36.52 |
| Heartflow, Inc. (HTFL) | United States | $4.225B |